核酸标记市场 - 全球产业规模、份额、趋势、机会及预测（按产品、类型、方法、应用、最终用户、地区和竞争格局划分），2021-2031年

全球核酸标记市场预计将从 2025 年的 34.1 亿美元成长到 2031 年的 53.1 亿美元，复合年增长率为 7.66%。

该过程涉及将可检测的标记物（例如萤光染料、酶或放射性同位素）透过化学或酶促方式连接到DNA或RNA分子上，从而使其能够在生物鑑定中被识别和追踪。基因组学研究的进步和对个人化医疗日益增长的需求是推动该行业发展的主要动力，而个人化医疗需要精准的诊断工具来实现个人化的患者治疗。例如，个人化医疗联盟报告称，FDA将在2024年核准18种新的个人化药物，约占所有新核准的治疗性分子实体的38%。这一趋势显着提升了标记技术在分子诊断和药物研发的效用。

儘管有这些正面迹象，但市场成长仍面临一个重大障碍：先进标记试剂和检测设备的高成本。不断上涨的成本限制了资源匮乏的研究环境中的应用，也阻碍了发展中地区的广泛普及。因此，儘管标记技术的应用范围正在扩大，但资金壁垒仍阻碍着其在全球不同市场的广泛应用。

市场驱动因素

次世代定序(NGS) 工作流程的技术进步是全球核酸标记市场的主要驱动力，这需要大量精确的试剂用于样品製备和序列检测。向自动化实验室工作流程和高通量筛检的转变，增加了酵素标记和萤光标记的消耗，而这些标记对于大规模产生可读基因组数据至关重要。随着定序能力的不断发展，对能够满足现代仪器高通量需求的兼容型先进标记试剂盒的需求也日益增长。例如，Illumina 公司在 2024 年 2 月提交的 10-K 表格报告显示，该公司在 2023 财年出货了 352 套高通量 NovaSeq X 系统，这凸显了高通量先进仪器的普及如何推动了对标记解决方案的需求，以高效管理海量数据集。

此外，慢性病和遗传性疾病（尤其是癌症）在全球范围内的日益流行，从根本上扩大了分子诊断的应用范围。临床检查室越来越依赖核酸标记技术来识别与复杂病理相关的基因突变和特定生物标记物，从而实现患者分层和早期诊断。根据美国癌症协会发布的《2024年癌症事实与数据》，预计美国新增癌症病例数将首次超过200万例，凸显了高灵敏度检测方法的紧迫感。为了支持应对这些健康挑战所需的生物医学研究，美国国立卫生研究院（NIH）已在2024年计画预算中拨出约471亿美元，为利用标记技术的研究活动提供大量资金。

市场挑战

先进试剂和设备所需的巨额资金投入是核酸标记领域发展的主要障碍。检测平台的高昂购置和维修成本限制了其应用，尤其是在资金紧张的学术机构和小规模受託研究机构中。当实验室无法承担高效能标记技术的资本支出时，他们就必须依赖过时的方法或降低实验通量，这直接减少了从相容耗材中获得的持续收入。

联邦政府对科研经费的停滞不前加剧了这种经济压力，严重影响了科研机构的购买力。据美国科学促进会（AAAS）称，美国国立卫生研究院（NIH）2024年的基本预算约为471亿美元，比前一年减少约1%。经费的减少迫使各机构将资源严格分配到关键任务上，而非高成本的诊断工具，导致在对资金较为敏感的市场中，已获批准的产品的推广速度放缓。

市场趋势

单细胞和空间基因组学中标记技术的应用日益广泛，从根本上改变了市场结构，优先考虑能够在生物组织结构内实现亚细胞分辨率的探针。这一趋势超越了批量定序，推动了先进条码化学和萤光染料的开发，这些技术能够在保持组织微环境完整性的同时绘製基因表现图谱。研究人员越来越多地采用这些高通量标记技术来原位可视化复杂的生物相互作用，这直接促进了相容仪器和专用试剂组的销售。为了说明这一转变，10x Genomics公司在2024年2月公布了2023年全年总收入为6.187亿美元，比上年增长20%，这主要得益于该公司空间分析和单细胞平台的强劲应用。

同时，随着化学修饰核酸的合成技术难度日益增加，将复杂的标记计划外包给受託研究机构（CRO）的做法日益普遍，这代表着一项重要的结构性变革。生物製药公司越来越多地将高级试剂（例如加帽mRNA和客製化标记的寡核苷酸）的生产外包给专业的CRO，以确保规模化生产并符合GMP标准。这种对外部专业知识的依赖使开发人员能够获得工业级的标记解决方案，同时避免内部合成过程中陡峭的学习曲线。例如，Maravai LifeSciences在2024年2月发布的报告显示，其核酸生产部门在2023年的收入累计2.248亿美元，这印证了市场对高品质外包合成和标记服务的巨大需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球核酸标记市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（试剂盒、试剂）
  • 按类型（放射性同位素/放射性标记、非放射性标记）
  • 透过方法（酵素法、化学法）
  • 依应用方法（定序、微阵列、原位杂合反应、印迹技术、聚合酵素链锁反应等）
  • 按最终用户划分（製药和生物技术公司、医院和诊断中心、学术和研究机构、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美核酸标记市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲核酸标记市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区核酸标记市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲核酸标记市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美核酸标记市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球核酸标记市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio
• New England Biolabs
• QIAGEN
• Promega
• PerkinElmer
• Zymo Research
• SeraCare Life Sciences

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Nucleic Acid Labeling Market is projected to expand from USD 3.41 Billion in 2025 to USD 5.31 Billion by 2031, reflecting a compound annual growth rate of 7.66%. This process entails the chemical or enzymatic attachment of detectable markers, such as fluorophores, enzymes, or radioisotopes, to DNA or RNA molecules to enable their identification and tracking within biological assays. The industry is largely driven by advancements in genomic research and the rising demand for personalized medicine, which necessitates precise diagnostic tools for tailoring patient treatments. For instance, the Personalized Medicine Coalition reported that in 2024, the FDA approved 18 new personalized medicines, representing approximately 38 percent of all newly approved therapeutic molecular entities, a trend that significantly enhances the utility of labeling technologies in molecular diagnostics and drug development.

Despite these positive indicators, market growth faces a substantial hurdle regarding the high cost of advanced labeling reagents and detection instruments. These elevated expenses restrict adoption within resource-constrained research environments and hinder broad accessibility in developing regions. Consequently, while the application of labeling technologies is expanding, financial barriers continue to impede widespread implementation across diverse global markets.

Market Driver

Technological advancements in Next-Generation Sequencing (NGS) workflows act as a primary catalyst for the Global Nucleic Acid Labeling Market, necessitating high volumes of precise reagents for library preparation and sequence detection. The shift toward automated laboratory workflows and high-throughput screening has intensified the consumption of enzymatic and fluorescent labels, which are crucial for generating readable genomic data at scale. As sequencing capabilities evolve, the demand for compatible, advanced labeling kits rises to meet the throughput of modern devices. For example, Illumina's February 2024 'Form 10-K' reported the shipment of 352 units of its high-throughput NovaSeq X system during the 2023 fiscal year, illustrating how the proliferation of high-capacity instrumentation fuels the need for sophisticated labeling solutions to manage vast datasets efficiently.

Additionally, the rising global prevalence of chronic diseases and genetic disorders, particularly cancer, fundamentally widens the scope of molecular diagnostics. Clinical laboratories increasingly rely on nucleic acid labeling to identify genetic mutations and specific biomarkers linked to complex pathologies, enabling patient stratification and early diagnosis. According to the American Cancer Society's 'Cancer Facts & Figures 2024', new cancer cases in the United States were projected to surpass the 2 million mark for the first time, underscoring the urgency for sensitive detection assays. To support the biomedical research necessary to tackle these health challenges, the National Institutes of Health secured a program level budget of approximately $47.1 billion in 2024, providing significant capital for research activities that utilize labeling technologies.

Market Challenge

The significant financial investment required for advanced reagents and instruments constitutes a primary barrier to the expansion of the nucleic acid labeling sector. High acquisition and maintenance costs for detection platforms limit their adoption, particularly within academic institutions and smaller contract research organizations that operate under strict fiscal constraints. When laboratories cannot justify the capital expenditure for premium labeling technologies, they are often forced to rely on older methods or reduce the scope of their experimental throughput, which directly diminishes the recurring revenue stream generated from compatible consumables.

This economic pressure is further intensified by stagnating federal support for scientific inquiry, which heavily influences the purchasing capacity of research facilities. According to the American Association for the Advancement of Science, in 2024, the National Institutes of Health received a base budget of roughly 47.1 billion dollars, marking a reduction of approximately one percent from the previous year. Such funding contractions compel institutions to allocate resources strictly toward essential operations rather than high-cost diagnostic tools, thereby slowing the uptake of labeling products in financially sensitive markets.

Market Trends

The expansion of labeling applications in Single-Cell and Spatial Genomics is fundamentally reshaping the market by prioritizing probes that deliver subcellular resolution within native tissue architectures. This trend moves beyond bulk sequencing, driving the development of advanced barcoding chemistries and fluorophores capable of mapping gene expression while preserving the tissue microenvironment. Researchers are increasingly adopting these high-plex labeling technologies to visualize complex biological interactions in situ, which directly fuels the sales of compatible instruments and proprietary reagent kits. Illustrating this shift, 10x Genomics reported in February 2024 that its total revenue for the full year 2023 reached $618.7 million, a 20 percent increase over the prior year, driven largely by the robust adoption of its spatial and single-cell platforms.

Concurrently, the growing practice of outsourcing complex labeling projects to Contract Research Organizations represents a critical structural evolution, as the synthesis of chemically modified nucleic acids becomes increasingly technically demanding. Biopharmaceutical companies are progressively delegating the manufacturing of sophisticated reagents, such as capped mRNA and custom-labeled oligonucleotides, to specialized CROs to ensure scalability and adherence to GMP standards. This reliance on external expertise allows developers to bypass the steep learning curves of in-house synthesis while accessing industrial-grade labeling solutions. Highlighting the scale of this sector, Maravai LifeSciences reported in February 2024 that its Nucleic Acid Production segment generated $224.8 million in revenue during 2023, underscoring the substantial market demand for high-quality outsourced synthesis and labeling services.

Key Market Players

• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio
• New England Biolabs
• QIAGEN
• Promega
• PerkinElmer
• Zymo Research
• SeraCare Life Sciences

Report Scope

In this report, the Global Nucleic Acid Labeling Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nucleic Acid Labeling Market, By Product

• Kits
• Reagents

Nucleic Acid Labeling Market, By Type

• Radioisotope/Radioactive Labelling
• Non-radioactive Labelling

Nucleic Acid Labeling Market, By Method

• Enzymatic
• Chemical

Nucleic Acid Labeling Market, By Application

• Sequencing
• Microarray
• In Situ Hybridization
• Blotting Techniques
• Polymerase Chain Reaction
• Others

Nucleic Acid Labeling Market, By End User

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Academic & Research Institutes
• Others

Nucleic Acid Labeling Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Labeling Market.

Available Customizations:

Global Nucleic Acid Labeling Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nucleic Acid Labeling Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Kits, Reagents)
  • 5.2.2. By Type (Radioisotope/Radioactive Labelling, Non-radioactive Labelling)
  • 5.2.3. By Method (Enzymatic, Chemical)
  • 5.2.4. By Application (Sequencing, Microarray, In Situ Hybridization, Blotting Techniques, Polymerase Chain Reaction, Others)
  • 5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, Academic & Research Institutes, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Nucleic Acid Labeling Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Method
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Nucleic Acid Labeling Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Method
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Nucleic Acid Labeling Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Method
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Nucleic Acid Labeling Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Method
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Nucleic Acid Labeling Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Method
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Nucleic Acid Labeling Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Method
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. France Nucleic Acid Labeling Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Method
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Nucleic Acid Labeling Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Method
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Nucleic Acid Labeling Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Method
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Nucleic Acid Labeling Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Method
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia Pacific Nucleic Acid Labeling Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Method
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Nucleic Acid Labeling Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Method
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Nucleic Acid Labeling Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Method
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Nucleic Acid Labeling Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Method
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Nucleic Acid Labeling Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Method
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Nucleic Acid Labeling Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Method
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. Middle East & Africa Nucleic Acid Labeling Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Method
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Nucleic Acid Labeling Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Method
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Nucleic Acid Labeling Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Method
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Nucleic Acid Labeling Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Method
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. South America Nucleic Acid Labeling Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Method
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Nucleic Acid Labeling Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Method
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Nucleic Acid Labeling Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Method
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Nucleic Acid Labeling Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Method
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Nucleic Acid Labeling Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Agilent Technologies
• 15.3. Takara Bio
• 15.4. New England Biolabs
• 15.5. QIAGEN
• 15.6. Promega
• 15.7. PerkinElmer
• 15.8. Zymo Research
• 15.9. SeraCare Life Sciences

16. Strategic Recommendations

17. About Us & Disclaimer